EUVIMED · CrossrefJournal
Lung Cancer Management
ISSN 1758-1966 · Informa UK Limited
Latest articles
Leveraging machine learning to predict de novo skin malignancy following lung transplantation
Cost of managing brain metastases in ALK-positive advanced NSCLC patients receiving first-line ALK TKIs in China
CyberKnife radical cure for early lung adenocarcinoma: a case was confirmed by postoperative pathology
At-home subcutaneous atezolizumab for non-small cell lung cancer: a prospective, single-arm phase II feasibility study
Potential to improve early detection of lung cancer through expansion of focused and opportunistic screening approaches: a scoping review focusing on potential expansion of screening risk factors and adoption of artificial intelligence models
An integrative systems biology framework decodes peripheral blood transcriptomic signatures, systemic interactome networks, and candidate targets in lung squamous cell carcinoma
Negative social determinants of health are linked to lung cancer screening underutilization
A Retrospective Study of Ensartinib-Treated ALK -Positive Locally Advanced or Metastatic NSCLC Patients in China
Enabling patients in effective self-management of breathlessness in lung cancer: the neglected pillar of personalized medicine
The Route to Diagnosis: Emergency Presentation of Lung Cancer
Nintedanib in Advanced NSCLC: Management of Adverse Events
Causes and Pathophysiology of Malignant Pleural Mesothelioma
Corrigendum
Novel Insights into the Pathophysiology And Treatment of Malignant Pleural Mesothelioma
Malignant Pleural Mesothelioma Signs and Symptoms
Diagnostic Tools and Staging of Malignant Pleural Mesothelioma
Surgery for Malignant Pleural Mesothelioma
Radiation Therapy for Malignant Pleural Mesothelioma
Malignant Pleural Mesothelioma: New Ideas Needed
The Role of Stereotactic Body Radiation Therapy in the Management of Oligometastatic Lung Cancer
The Future of Immunotherapy in the Treatment of Lung Cancer
Erratum
EGFR Testing and the CAP/IASLC/AMP Lung Cancer Biomarker Testing Guidelines: Knowledge Gaps and Future Directions
IMPRESS is Impressing
Use of TUBB3 for Patient Stratification and Prognosis in Lung Cancer
Therapeutic Options in Advanced Squamous Cell Lung Carcinoma
Cardiothoracic Surgery and Lung Cancer
Assessing the Benefits and Harms of Low-Dose Computed Tomography Screening For Lung Cancer
Oncogenic ALK fusion in rare subtype of small intestine metastasis from occult lung cancer
Moving towards single fraction peripheral lung stereotactic body radiation therapy: patient care during and after the global COVID-19 pandemic
EUVIMED